...
首页> 外文期刊>European review for medical and pharmacological sciences. >MicroRNA-338 inhibits proliferation, migration, and invasion of gastric cancer cells by the Wnt/β-catenin signaling pathway
【24h】

MicroRNA-338 inhibits proliferation, migration, and invasion of gastric cancer cells by the Wnt/β-catenin signaling pathway

机译:MicroRNA-338通过Wnt /β-catenin信号通路抑制胃癌细胞的增殖,迁移和侵袭

获取原文

摘要

OBJECTIVE: Emerging evidence suggests aberrant microRNAs (miRNAs) expression is involved in cancer development through multiple. Although miR338 has shown to have tumor suppression ability and anti-migration effects in some cancers, its regulatory role and molecular mechanism in the development of gastric cancer cells yet remains little known. This work aims to investigate miR-338 in regulating Wnt/β-catenin pathway in epithelial-mesenchymal transition (EMT) in gastric cancers. MATERIALS AND METHODS: Human gastric cancer cells were transfected with either miR-338 mimic or erythropoietin-producing hepatocellular (Eph)A2-targeting siRNA. The biological function of miR-338 in gastric cancer cells was investigated using a MTT assay and invasion assay. Western blot assay was used to measure the levels of EphA2, GSK-3β, phospho-GSK-3βSer9, c-Myc, E-cadherin, Vimentin, and β-catenin of at protein level. RESULTS: Our data showed that miR-338 inhibited proliferation, migration and invasion of human gastric cancer cells. miR-338 affected the Wnt/β-catenin pathway by increasing p-GSK-3βSer9 and decreasing GSK-3βSer9 and c-Myc at protein levels. EphA2 protein level was downregulated and positively correlated with EMT markers. Both silencing of EphA2 and transfection with miR-338 mimic resulted in the up-regulation of the EMT molecular marker E-cadherin and down-regulation of Vimentin and β-catenin at protein levels. CONCLUSIONS: This study indicated that miR-338 is a potential tumor suppressor in gastric cancer and miR-338 inhibited EMT of gastric cancer cells through deactivation of Wnt/β-catenin signaling targeting at EphA2.
机译:目的:新兴证据表明微小RNA(miRNA)的异常表达通过多种途径参与了癌症的发展。尽管miR338已显示在某些癌症中具有肿瘤抑制能力和抗迁移作用,但其在胃癌细胞发展中的调控作用和分子机制仍然鲜为人知。这项工作旨在研究miR-338在胃癌上皮-间质转化(EMT)中调控Wnt /β-catenin途径的作用。材料与方法:用miR-338模拟或产生促红细胞生成素的肝细胞(Eph)A2靶向siRNA转染人胃癌细胞。使用MTT测定法和侵袭测定法研究miR-338在胃癌细胞中的生物学功能。蛋白质印迹法用于在蛋白质水平上测量EphA2,GSK-3β,磷酸GSK-3βSer9,c-Myc,E-钙粘蛋白,波形蛋白和β-连环蛋白的水平。结果:我们的数据显示miR-338抑制人胃癌细胞的增殖,迁移和侵袭。 miR-338在蛋白质水平上通过增加p-GSK-3βSer9并减少GSK-3βSer9和c-Myc来影响Wnt /β-catenin途径。 EphA2蛋白水平下调并与EMT标记呈正相关。 EphA2沉默和miR-338模拟转染均导致EMT分子标记E-钙粘着蛋白的上调和波形蛋白和β-连环蛋白的下调。结论:这项研究表明,miR-338是胃癌的一种潜在的肿瘤抑制因子,而miR-338通过使针对EphA2的Wnt /β-catenin信号传导失活而抑制了胃癌细胞的EMT。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号